logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: carcinoma
Load new posts () and activity
Like Reblog Comment
text 2018-06-14 12:07
Hepatocellular Carcinoma Drugs Market - Global Industry Insights, 2026

Hepatocellular carcinoma (HCC) is a major type of primary liver cancer that arises from the liver cells or hepatocytes. The disease is found to occur mainly in patients with hepatitis B, hepatitis C, cirrhosis, obesity, and diabetes. Diagnosis of hepatocellular carcinoma is mainly done by imaging tests such as ultrasound, MRI, CT scan, and liver biopsy. Treatment for hepatocellular carcinoma mainly includes radiation therapy, ablation therapy in addition to chemotherapy and targeted drug therapy.

 

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1596

 

A majority of the HCC patients are diagnosed at the end-stage of liver dysfunction. Due to poor prognosis of the condition, mortality rate is approximately the same as the incidence rate. Therefore, early detection of the cancer is an important parameter to improve the survival of affected patients, thus aiding in growth of the global hepatocellular carcinoma drugs market.

 

Increasing incidence of global hepatocellular carcinoma cases is a major factor augmenting market growth. According to the research by International Journal of Cancer Research and Treatment, 2014, HCC is the sixth most common type of cancer worldwide and third most common cause of death worldwide, fifth for men and eighth for women. The disease accounts for more than 5% of all cancers and for 80-90% of primary liver cancers. Also, according to the Addis Ababa University, 2017, hepatocellular carcinoma (HCC) accounted to 854,000 new cases of liver cancer and 810,000 related deaths in 2015. Furthermore, increasing incidence and mortality of hepatocellular carcinoma is attributed to the emergence of new risk factors such as hepatitis B and C viral infections, metabolic disorders such as diabetes and non-alcoholic fatty liver disease, and exposure to toxins such as alcohol and aflatoxin.

 

Click To Continue Reading on Hepatocellular Carcinoma Drugs Market

 

About Coherent Market Insights:

 

 

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Contact Us:

 

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Visit our news Website: https://www.coherenttimes.org/



Like Reblog Comment
url 2015-03-31 22:24
Cancer Immunization by Dr. Gregory J. Berry

Dr. Gregory J. Berry’s new book, Cancer Immunization, is out now!

For the first time in history, a new path to cancer prevention for those over 40 years of age is disclosed. The common denominator and other bioactive compounds of three different medicinal mushrooms from Japan, China and the Himalayas respected for two millennia have been discovered and Western research into them is presented.

More posts
Your Dashboard view:
Need help?